Neuroene Therapeutics - News

Neuroene Therapeutics

Home
Contact
News
Investors
DATA AND PUBLICATIONS

Home
Contact
News
Investors
DATA AND PUBLICATIONS

Selection of Neuroene Therapeutics as an Early-Stage presenting company at the SEBIO Investor Forum in Atlanta

10/11/2018

https://www.southeastbio.org/

Neuroene Therapeutics awarded NIH Phase II SBIR

8/18/2018

https://projectreporter.nih.gov/project_info_description.cfm?aid=9558194&icde=40805181

SCRA/FRD pilot grant awarded for Parkinson's Disease study

6/25/2018

Invited pitch presentation at NISBRE 2018

6/23/2018

For the "Entrepreneurship: turning your innovative ideas into a marketable product" workshop.

Patent issued

1/9/2018

Compositions and methods for treating neurological diseases or injury. Issued on January 9, 2018
https://patents.google.com/patent/US9861596B2/en

Charleston Angel Conference - Pitch

9/20/2017

http://www.charlestonangelconference.com/agenda

Notice of Allowance received from U.S. Patent and Trademark Office for "Compositions And Methods For Treating Neurological Diseases Or Injury"

9/14/2017

Oral presentation at the Environmental Mutagenesis & Genomics Society meeting in Raleigh, NC

9/9/2017

www.emgs-us.org/page/saturday-agenda

Oral Presentation at the United Mitochondrial Disease Foundation meeting 2017

6/28/2017

www.umdf.org/symposium/

First place winner at the UMDF meeting 2017.

"Recovery of mtDNA stability, bioenergetics and lifespan in animal models of mtDNA depletion syndrome through new mitochondrial targeting compounds"

Oral Presentation at Experimental Biology 2017

4/23/2017

http://experimentalbiology.org/PDFS/2017/2017-EB-Oral-Sessions.aspx

Author

Write something about yourself. No need to be fancy, just an overview.

Archives

June 2018
January 2018
September 2017
June 2017
April 2017
March 2017
November 2016
August 2016
July 2016
November 2015

Categories

Powered by

Create your own unique website with customizable templates.